Претраживање
Приказ резултата 1-3 од 3
A review of perfos in fda and ema labelling claims (2009-2019)
(Elsevier Science Inc, New York, 2019)
Disease specific patient-reported outcome (pro) instruments for hematologic malignancies (hm)
(Elsevier Science Inc, New York, 2019)
Patient-reported outcomes used in clinical trials of systemic lupus erythematosus: a review of suitability for FDA labelling claims
(Elsevier Science Inc, New York, 2019)